Revvity | PKI - Current Liabilities


Revvity reported $1.24B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Agilent USD 2.27B 35M Mar/2026
Align Technology USD 1.91B 2.74M Jun/2026
Bio Techne USD 153.28M 12.85M Mar/2026
Bio-Rad Laboratories USD 917M 400M Mar/2026
Bruker USD 1.36B 75.9M Mar/2026
Celltrion KRW 292.71B 9.09B Mar/2026
Charles River Laboratories USD 1.09B 26.61M Mar/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Danaher USD 8.1B 645M Jun/2026
Dentsply International USD 1.21B 136M Mar/2026
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 38.28M 7.55M Mar/2026
Divis Laboratories Ltd INR 20.43B 3.15B Mar/2026
Edwards Lifesciences USD 1.41B 404.7M Mar/2026
Illumina USD 1.58B 12M Jun/2026
Intuitive Surgical USD 2.58B 65.1M Jun/2026
IQVIA Holdings USD 8.82B 486M Jun/2026
Kangmei Pharma CNY 5.38B 433.79M Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Laboratory Of America USD 2.12B 516.4M Jun/2026
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Mettler Toledo International USD 1.2B 92.14M Jun/2026
Myriad Genetics USD 130.7M 500K Jun/2026
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
OraSure Technologies USD 44.08M 4.29M Mar/2026
Organigram Holdings CAD 88.74M 5.31M Mar/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pacific Biosciences Of California USD 65.36M 7.48M Mar/2026
Pharma Mar EUR 98.42M 9.2M Jun/2026
Qiagen NV USD 479.11M 33.03M Mar/2026
Quest Diagnostics USD 1.79B 389M Jun/2026
Quidel USD 962.4M 3.7M Mar/2026
Repligen USD 132.66M 6.45M Jun/2026
Revvity USD 1.24B 92.6M Mar/2026
Sartorius EUR 1.44B 668.7M Jun/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Thermo Fisher Scientific USD 15.07B 448M Jun/2026
Tilray USD 259.32M 8.32M Sep/2025
Waters USD 1.24B 11.8M Dec/2025
Zealand Pharma A/S 404M 260.96M Mar/2026
Zz Pientze Pharmaceu CNY 2.28B 134.52M Mar/2026